Voiant is the industry leading AI-based clinical trial imaging solution…
with unparalleled scientific and clinical domain expertise, providing biopharmaceutical companies with high-speed delivery of quality clinical endpoint data. Three industry leading companies—MedQIA, WorldCare Clinical and DARC—have come together to form Voiant, the new leader in clinical trial imaging endpoint data.
Voiant integrates AI leadership and visionary computing with key opinion leaders in strategic therapeutic areas and clinical research experts. This powerful combination ensures seamless operations and reliable execution, providing the shortest path to the highest quality imaging data for clinical trials.
Voiant has interpreted over half a billion images from thousands of global clinical trials, aiding the companies that bring new treatments to patients across oncology, respiratory, ophthalmology, cardiovascular, gastrointestinal, and liver disease domains.
Patients are at the heart of everything we do. Our clients and partners develop groundbreaking treatments and technologies to help patients in need, and our imaging services provide the data that keeps their programs moving forward.
At Voiant, we are on the journey to the future of healthcare. Working alongside top client sponsors, we are changing the status quo for patient imaging in clinical trials.
Experience the better approach to clinical imaging endpoint data. Schedule an exploratory discussion to learn more.